(Q39473584)

12 September 2017

title

Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin (English)

1 reference

12 September 2017

1 reference

Van den Bergh P

1

1 reference

12 September 2017

Francart J

2

1 reference

12 September 2017

Mourin S

3

1 reference

12 September 2017

Kollmann P

4

1 reference

12 September 2017

Laterre EC

5

1 reference

12 September 2017

publication date

1 July 1995

1 reference

12 September 2017

1 reference

12 September 2017

volume

18

1 reference

12 September 2017

issue

7

1 reference

12 September 2017

page(s)

720-729

1 reference

Long-term results and complications of botulinum A toxin in the treatment of blepharospasm

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMUS.880180708

Effectiveness of botulinum toxin therapy for essential blepharospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMUS.880180708

Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMUS.880180708

Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMUS.880180708

Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMUS.880180708

Hemifacial spasm treated with botulinum A toxin injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMUS.880180708

Botulinum toxin therapy for limb dystonias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMUS.880180708

21 January 2018

Identifiers

DOI

10.1002/MUS.880180708

1 reference

12 September 2017

1 reference